Strictly for Babies: Hyland’s Teething Tablets

Hyland’s medicinal products have been selling since the first Pulitzer Prize was given. The brand has offered, to both Canada and the United States, its remedies for over 100 years. Its children’s products use ingredients and dosages that are measured for kids, and Hyland’s Teething Tablets are a part of that selection.

Looking for the Signs of a Teething Baby

You should prepare yourself for teething and learn how to reduce your child’s struggle with it. A baby’s first year is when their teeth start growing, and the pain causes restlessness, severe crying and less sleep at night. Parents need effective remedies as they deal with this; ensuring that the teeth grow well is a part of raising a healthy kid.

The two, incisor teeth, found right at the front of the mouth, are likely to start showing first. These will, with no doubt, create a cute smile and some fun memories, but consider the real experience your child is having. Your baby’s first birthday is when you’re likely to find the molars settling in, and these come in a count of eight.

Drooling is to be expected. Reducing their pain can help to decrease the amount of saliva they have. You’ll do less cleaning, and the urge that babies have for gnawing also reduces with treatment. Treatment is where Hyland’s products come into play. This homeopathic brand uses a container of 162 teething tablets for pain relief in babies.

What are Hyland’s Teething Tablets?

Here’s a look at the performance to expect from Hyland’s Teething Tablets:

Quick and Gentle

  • Quick and Gentle: The working ingredients are subtle and only target the areas where babies experience pain.


  • Natural: Being entirely homeopathic leads the brand to rely solely on natural ingredients. These ingredients have been improved on since 2016.

No Artificial Flavors

  • No Artificial Flavors: Adding in artificial chemicals can often be dangerous, and for this reason, even artificial flavors are left out.

For Swollen Gums

  • For Swollen Gums: Consider this remedy when you notice swollen gums in your child’s mouth. There’s a soothing action to put to work with these tablets.

Fast Dissolvents

  • Fast Dissolvents: Each tablet dissolves quickly and leaves nothing behind for your child to play with.

Here is what you need to know about teething tablets

Dr. Ira Kirschenbaum on the History of Orthopaedics

 Dr. Ira Kirschenbaum, M.D., is a leading expert in orthopaedics (orthopedics) and is among the best surgeons in the United Status. He plays an active role in teaching the general public about the history and advancements in orthopaedics. Orthopedic medicine is geared toward helping injuries related to the musculoskeletal system, including correcting bone, muscle and joint deformities and other physical injuries. Dr. Ira Kirschenbaum has focused his studies on practical solutions to physical injuries, as well as the effects of aging on the musculoskeletal system.

French physician Dr. Nicolas Andry can be credited with the rise of orthopaedics as a distinguished field, as it was his book, “Orthopédie,” written in 1741, that brought public attention to orthopedic practices. However, orthopedics can be traced as far back as 4500 B.C.E. Skeletons of Neolithic Stone Age people show evidence that bone breaks were reset and healed properly. Ancient Babylon also practiced bone setting. Egyptians practiced using splints for injuries. The Greek father of medicine, Hippocrates, also had a hand in orthopedics, as did the Roman physician Galen of Pergamon. After Rome’s fall, orthopedics did not advance much until the ninth century with the rise in medical schools across Europe. In modern times, the development of better technology and increased understanding of health and medicine has assisted the advancement of orthopedics.

The focus of orthopedics has long been to correct injuries and deformities to bones, joints, and muscles. Knee and hip surgeries are currently the most common and well known orthopedic procedures. Experts like Dr. Ira Kirschenbaum receive a lot of media attention for their skills at replacing faulty joints with artificial implants. Fifty years ago, such replacements weren’t possible.

Dr. Ira Kirschenbaum is a modern, notable figure in orthopedics. He is an innovative design expert and has helped develop several joint replacement systems used in surgeries today. He has performed thousands of joint replacement surgeries and also lectures and publishes material to educate the public about orthopedics. Orthopedics is a continually growing field affected by medical and technical advancements and Dr. Ira Kirschenbaum has definitely had a hand in its growth.

Find out more about Dr. Ira here

Amicus Therapeutics: A Leader in Treating Rare Genetic Diseases

Amicus Therapeutics is a biopharmaceutical company that was founded in 2002. Its main focus is on rare genetic diseases. The company went public in 2007. It is a small company with less than a 100 employees as of 2013. The company is based in Cranbury, New Jersey but opened a second site in San Diego, California in 2008. John F. Crowley is the chairman of the board and chief executive officer of Amicus Therapeutics. He has led the company since 2005 ( Amicus Therapeutics has been the leader in four major programs that I will discuss below.


Fabry Disease Program


Fabry disease causes permanent organ damage to critical body systems and tissues. The symptoms are typically severe and begin early in life. Although there is no cure, Amicus Therapeutics is currently developing a new promising treatment.


Epidermolysis Bullosa Program


Epidermolysis Bullosa is a rare genetic disease that blisters and damages the skin. In some extreme cases, it can damage the lining of some organs. It can also be disfiguring and fatal in some cases. Unfortunately, there is currently no cure or approved treatment for this disease. Although, Amicus Therapeutics is providing hope by developing a topical treatment for the blisters and other external skin problems.


Pompe Disease Program


Pompe Disease is a inherited disease that affects the muscles and other tissues due to the lack of the enzyme acid alpha-glucosidase. It can cause muscle weakness and respiratory problems. There is currently no cure or effective treatment, but Amicus Therapeutics is developing a treatment program.


Preclinical Programs


Amicus Therapeutics has two potentially groundbreaking preclinical programs in development. The first is Lysosomal Storage Disorders. This program hopes to use enzyme replacement therapy to treat or cure the disorder (Google Finance). The second is CDKL5 Deficiency. CDLK5 is a protein that is critical for brain development. It is debilitating for most children. Amicus Therapeutics is currently developing a protein replacement therapy approach to treat this disease.


As you can see, Amicus Therapeutics is an extraordinary company that is working very hard to provide cures or treatments for rare and deadly diseases. Because of them, many people now have hope for their conditions.